Global Stem Cell and Regenerative Therapy Market: A BCC Research Outlook
REPORT SCOPE:
The scope of this report is broad and covers various type of product available in the stem cell and regenerative medicines market and potential application sectors across various industries. The current report offers a detailed analysis of the stem cell and regenerative medicines market.
The report highlights the current and future market potential of stem cell and regenerative medicines and provides a detailed analysis of the competitive environment, recent development, merger and acquisition, drivers, restraints, and technology background in the market. The report also covers market projections through 2024.
The report details market shares of stem cell and regenerative medicines based on products, application, and geography. Based on product the market is segmented into therapeutic products, cell banking, tools and reagents. The therapeutics products segments include cell therapy, tissue engineering and gene therapy. By application, the market is segmented into oncology, cardiovascular disorders, dermatology, orthopedic applications, central nervous system disorders, diabetes, others
The market is segmented by geography into the following regions: North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. The report presents detailed analyses of major countries such as the U.S., Canada, Mexico, Germany, the U.K. France, Japan, China and India. For market estimates, data is provided for 2018 as the base year, with forecasts for 2019 through 2024. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
REPORT INCLUDES:
The scope of this report is broad and covers various type of product available in the stem cell and regenerative medicines market and potential application sectors across various industries. The current report offers a detailed analysis of the stem cell and regenerative medicines market.
The report highlights the current and future market potential of stem cell and regenerative medicines and provides a detailed analysis of the competitive environment, recent development, merger and acquisition, drivers, restraints, and technology background in the market. The report also covers market projections through 2024.
The report details market shares of stem cell and regenerative medicines based on products, application, and geography. Based on product the market is segmented into therapeutic products, cell banking, tools and reagents. The therapeutics products segments include cell therapy, tissue engineering and gene therapy. By application, the market is segmented into oncology, cardiovascular disorders, dermatology, orthopedic applications, central nervous system disorders, diabetes, others
The market is segmented by geography into the following regions: North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. The report presents detailed analyses of major countries such as the U.S., Canada, Mexico, Germany, the U.K. France, Japan, China and India. For market estimates, data is provided for 2018 as the base year, with forecasts for 2019 through 2024. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
REPORT INCLUDES:
- 28 data tables
- An overview of global markets for stem cell and regenerative medicines
- Analyses of global market trends, with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Details of historic background and description of embryonic and adult stem cells
- Information on stem cell banking and stem cell research
- A look at the growing research & development activities in regenerative medicine
- Coverage of ethical issues in stem cell research & regulatory constraints on biopharmaceuticals
- Comprehensive company profiles of key players in the market, including Aldagen Inc., Caladrius Biosciences Inc., Daiichi Sankyo Co. Ltd., Gamida Cell Ltd. and Novartis AG
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Overview: Cells
Overview: Stem Cell
Embryonic Stem Cell (ES)
Growth and Identification of Embryonic Stem Cells
Stimulating Embryonic Stem Cells to Differentiate
Adult Stem Cell
Mesenchymal Stem Cells
Hematopoietic Stem Cells
Neural Stem Cell
Endothelial Progenitor Cell
Epithelial Stem Cell
Very Small Embryonic-Like Cell
Cord Blood Stem Cell
Induced Pluripotent Stem Cells
Evolution of Induced Pluripotent Stem Cell Research
Advantages
Disadvantages
Cellular Reprogramming in Stem Cells
Human Parthenogenetic Stem Cells
Limitations in Stem Cell and Regenerative Therapy
Cancer Stem Cells
Historic Background of Stem Biology
Stem Cell Research
Stem Cell Research Centers
Stem Cell Production
Stem Cell Acquisition
Characterization and Expansion
Maintenance and Storage
Stem Cell Production Economics
Customized Therapy
Overview: Regenerative Medicine
CHAPTER 4 MARKET DYNAMICS
Market Drivers
Increasing Emphasis on Stem Cell Research
Growing Research and Development Activities in Regenerative Medicine
Rise in Prevalence of Trauma Emergencies and Chronic Diseases
Technological Advancement in Stem Cell Tools and Products
Market Restraints
Ethical Issues in Stem Cell Research & Regulatory Constraints on Biopharmaceuticals
Dearth of Skilled Technicians and Poor Infrastructure for Cell Culture Technology
High Treatment Cost and Operational Inefficiency Associated with Stem Cell Research
CHAPTER 5 MARKET BREAKDOWN BY PRODUCT
Global Stem Cell and Regenerative Medicines Market, by Product
Therapeutic Products
Market Size and Forecast
Cell Therapies
Tissue Engineering
Gene Therapy
Cell Banking
Market Size and Forecast
Market Analysis
Tools and Reagents
Market Size and Forecast
Market Analysis
CHAPTER 6 MARKET BREAKDOWN BY APPLICATION
Global Stem Cell and Regenerative Medicines Market, by Application
Oncology
Market Size and Forecast
Market Analysis
Cardiovascular Disorders
Market Size and Forecast
Market Analysis
Dermatology
Market Size and Forecast
Market Analysis
Orthopedic
Market Size and Forecast
Market Analysis
Central Nervous System Disorders
Market Size and Forecast
Market Analysis
Diabetes
Market Size and Forecast
Market Analysis
Others
Market Size and Forecast
Market Analysis
CHAPTER 7 MARKET BREAKDOWN BY REGION
Global Market for Stem Cell and Regenerative Medicines, by Region
North America
United States
Canada
Mexico
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
South America
Middle East and Africa
CHAPTER 8 REGULATORY SCENARIO
Stem Cell Regulation
Australia
Brazil
Canada
China
France
Germany
India
Ireland
Israel
Italy
Japan
South Korea
Spain
U.K.
U.S.
European Union
CHAPTER 9 PATENT ANALYSIS
Patent Analysis
Tissue Engineering and Regeneration Patent
Japan Patent Analysis
Europe Patent Analysis
U.S. Patent Analysis
Stem Cell Patents
Patentability of Stem Cell Lines
Policies by Country
CHAPTER 10 COMPETITIVE LANDSCAPE
Merger and Acquisitions
Merger and Acquisitions in 2019 (Till April 2019)
Merger and Acquisitions in 2018
Merger and Acquisitions in 2017
Partnerships and Collaborations
Product Launches
CHAPTER 11 COMPANY PROFILES
3DMATRIX
ALDAGEN INC.
ARTERIOCYTE
ATHERSYS INC.
BEIKE BIOTECHNOLOGY CO. LTD.
BIOTIME INC.
BRAINSTORM CELL THERAPEUTICS INC.
BOEHRINGER INGELHEIM GMBH
CALADRIUS BIOSCIENCES INC.
CAPRICOR INC.
CELLERANT THERAPEUTICS INC.
CERAPEDICS INC.
CELLULAR DYNAMICS INTERNATIONAL
CELYAD
CRYOLIFE INC.
CYTORI THERAPEUTICS INC.
DAIICHI SANKYO CO. LTD.
EPISTEM LTD.
GAMIDA CELL LTD.
GILEAD SCIENCES INC.
GLOBALSTEM
HYBRID ORGAN GMBH
INTERNATIONAL STEM CELL CORPORATION
JUVENTAS THERAPEUTICS INC.
MESOBLAST LTD.
NOVARTIS AG
NUO THERAPEUTICS INC. (CYTOMEDIX INC.)
OCATA
ORGANOGENESIS INC. (ADVANCED BIOHEALING)
OSIRIS THERAPEUTICS INC.
PRIMEGEN BIOTECH LLC
RENEURON GROUP
STEM CELLS INC.
STEMEDICA CELL TECHNOLOGIES INC.
STEMINA BIOMARKER DISCOVERY INC.
STEMPEUTICS
TIGENIX NV (A PART OF TAKEDA PHARMACEUTICAL COMPANY LIMITED)
U.S. STEM CELL INC.
VERICEL CORPORATION
VERISTEM
VIACYTE INC.
VITRO DIAGNOSTICS INC.
WICELL RESEARCH INSTITUTE
CHAPTER 12 APPENDIX: ABBREVIATIONS
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Overview: Cells
Overview: Stem Cell
Embryonic Stem Cell (ES)
Growth and Identification of Embryonic Stem Cells
Stimulating Embryonic Stem Cells to Differentiate
Adult Stem Cell
Mesenchymal Stem Cells
Hematopoietic Stem Cells
Neural Stem Cell
Endothelial Progenitor Cell
Epithelial Stem Cell
Very Small Embryonic-Like Cell
Cord Blood Stem Cell
Induced Pluripotent Stem Cells
Evolution of Induced Pluripotent Stem Cell Research
Advantages
Disadvantages
Cellular Reprogramming in Stem Cells
Human Parthenogenetic Stem Cells
Limitations in Stem Cell and Regenerative Therapy
Cancer Stem Cells
Historic Background of Stem Biology
Stem Cell Research
Stem Cell Research Centers
Stem Cell Production
Stem Cell Acquisition
Characterization and Expansion
Maintenance and Storage
Stem Cell Production Economics
Customized Therapy
Overview: Regenerative Medicine
CHAPTER 4 MARKET DYNAMICS
Market Drivers
Increasing Emphasis on Stem Cell Research
Growing Research and Development Activities in Regenerative Medicine
Rise in Prevalence of Trauma Emergencies and Chronic Diseases
Technological Advancement in Stem Cell Tools and Products
Market Restraints
Ethical Issues in Stem Cell Research & Regulatory Constraints on Biopharmaceuticals
Dearth of Skilled Technicians and Poor Infrastructure for Cell Culture Technology
High Treatment Cost and Operational Inefficiency Associated with Stem Cell Research
CHAPTER 5 MARKET BREAKDOWN BY PRODUCT
Global Stem Cell and Regenerative Medicines Market, by Product
Therapeutic Products
Market Size and Forecast
Cell Therapies
Tissue Engineering
Gene Therapy
Cell Banking
Market Size and Forecast
Market Analysis
Tools and Reagents
Market Size and Forecast
Market Analysis
CHAPTER 6 MARKET BREAKDOWN BY APPLICATION
Global Stem Cell and Regenerative Medicines Market, by Application
Oncology
Market Size and Forecast
Market Analysis
Cardiovascular Disorders
Market Size and Forecast
Market Analysis
Dermatology
Market Size and Forecast
Market Analysis
Orthopedic
Market Size and Forecast
Market Analysis
Central Nervous System Disorders
Market Size and Forecast
Market Analysis
Diabetes
Market Size and Forecast
Market Analysis
Others
Market Size and Forecast
Market Analysis
CHAPTER 7 MARKET BREAKDOWN BY REGION
Global Market for Stem Cell and Regenerative Medicines, by Region
North America
United States
Canada
Mexico
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
South America
Middle East and Africa
CHAPTER 8 REGULATORY SCENARIO
Stem Cell Regulation
Australia
Brazil
Canada
China
France
Germany
India
Ireland
Israel
Italy
Japan
South Korea
Spain
U.K.
U.S.
European Union
CHAPTER 9 PATENT ANALYSIS
Patent Analysis
Tissue Engineering and Regeneration Patent
Japan Patent Analysis
Europe Patent Analysis
U.S. Patent Analysis
Stem Cell Patents
Patentability of Stem Cell Lines
Policies by Country
CHAPTER 10 COMPETITIVE LANDSCAPE
Merger and Acquisitions
Merger and Acquisitions in 2019 (Till April 2019)
Merger and Acquisitions in 2018
Merger and Acquisitions in 2017
Partnerships and Collaborations
Product Launches
CHAPTER 11 COMPANY PROFILES
3DMATRIX
ALDAGEN INC.
ARTERIOCYTE
ATHERSYS INC.
BEIKE BIOTECHNOLOGY CO. LTD.
BIOTIME INC.
BRAINSTORM CELL THERAPEUTICS INC.
BOEHRINGER INGELHEIM GMBH
CALADRIUS BIOSCIENCES INC.
CAPRICOR INC.
CELLERANT THERAPEUTICS INC.
CERAPEDICS INC.
CELLULAR DYNAMICS INTERNATIONAL
CELYAD
CRYOLIFE INC.
CYTORI THERAPEUTICS INC.
DAIICHI SANKYO CO. LTD.
EPISTEM LTD.
GAMIDA CELL LTD.
GILEAD SCIENCES INC.
GLOBALSTEM
HYBRID ORGAN GMBH
INTERNATIONAL STEM CELL CORPORATION
JUVENTAS THERAPEUTICS INC.
MESOBLAST LTD.
NOVARTIS AG
NUO THERAPEUTICS INC. (CYTOMEDIX INC.)
OCATA
ORGANOGENESIS INC. (ADVANCED BIOHEALING)
OSIRIS THERAPEUTICS INC.
PRIMEGEN BIOTECH LLC
RENEURON GROUP
STEM CELLS INC.
STEMEDICA CELL TECHNOLOGIES INC.
STEMINA BIOMARKER DISCOVERY INC.
STEMPEUTICS
TIGENIX NV (A PART OF TAKEDA PHARMACEUTICAL COMPANY LIMITED)
U.S. STEM CELL INC.
VERICEL CORPORATION
VERISTEM
VIACYTE INC.
VITRO DIAGNOSTICS INC.
WICELL RESEARCH INSTITUTE
CHAPTER 12 APPENDIX: ABBREVIATIONS
LIST OF TABLES
Summary Table: Global Stem Cell and Regenerative Medicines Market, by Region, Through 2024
Table 1: Investments in Stem Cell Research
Table 2: Snapshot of Regenerative Product Pipeline
Table 3: Ethical Issues in Different Phases of Stem Cell Research
Table 4: Global Stem Cell and Regenerative Medicines Market, by Product, Through 2024
Table 5: Global Stem Cell and Regenerative Therapeutic Products Market, byType, Through 2024
Table 6: Cell-Based Immunotherapy Products
Table 7: Stem Cells, Advantages and Clinical Trials in Cardiovascular Disease Treatment
Table 8: Tissue-Engineered Products
Table 9: Clinical Trials of Rare Diseases, by Technology, 2018
Table 10: Gene Therapy Products
Table 11: Recent Developments in the Stem Cell Reagents, 2016-2019
Table 12: Global Stem Cell and Regenerative Medicines Market, by Application, Through 2024
Table 13: Cell Therapies by Different Companies to Treat Cardiovascular Diseases
Table 14: Global and U.S. Statistics for Skin Damage Medical Conditions, 2018
Table 15: Cellular Skin Tissue-Engineered Products in the Market
Table 16: Orthopedic Diseases by Region: Key Facts
Table 17: Demineralized Bone Matrix Products Cleared by FDA
Table 18: Global Stem Cell and Regenerative Medicines Market, by Region, Through 2024
Table 19: Regenerative Medicine Companies, by Size and Region, 2018
Table 20: North American Stem Cell and Regenerative Medicines Market, by Country, Through 2024
Table 21: European Stem Cell and Regenerative Medicines Market, by Country, Through 2024
Table 22: Asia-Pacific Stem Cell and Regenerative Medicines Market, by Country, Through 2024
Table 23: Regenerative Medical Products Approved in Japan Since the New Regenerative Medicine Legislation
Table 24: Japan Tissue Engineering and Regeneration Technologies Patents, 2016-February 2019
Table 25: Europe Tissue Engineering and Regeneration Technologies Patents, 2016-February 2019
Table 26: U.S. Tissue Engineering and Regeneration Technologies Patents, 2016-February 2019
Table 27: Abbreviations Used in This Report
Summary Table: Global Stem Cell and Regenerative Medicines Market, by Region, Through 2024
Table 1: Investments in Stem Cell Research
Table 2: Snapshot of Regenerative Product Pipeline
Table 3: Ethical Issues in Different Phases of Stem Cell Research
Table 4: Global Stem Cell and Regenerative Medicines Market, by Product, Through 2024
Table 5: Global Stem Cell and Regenerative Therapeutic Products Market, byType, Through 2024
Table 6: Cell-Based Immunotherapy Products
Table 7: Stem Cells, Advantages and Clinical Trials in Cardiovascular Disease Treatment
Table 8: Tissue-Engineered Products
Table 9: Clinical Trials of Rare Diseases, by Technology, 2018
Table 10: Gene Therapy Products
Table 11: Recent Developments in the Stem Cell Reagents, 2016-2019
Table 12: Global Stem Cell and Regenerative Medicines Market, by Application, Through 2024
Table 13: Cell Therapies by Different Companies to Treat Cardiovascular Diseases
Table 14: Global and U.S. Statistics for Skin Damage Medical Conditions, 2018
Table 15: Cellular Skin Tissue-Engineered Products in the Market
Table 16: Orthopedic Diseases by Region: Key Facts
Table 17: Demineralized Bone Matrix Products Cleared by FDA
Table 18: Global Stem Cell and Regenerative Medicines Market, by Region, Through 2024
Table 19: Regenerative Medicine Companies, by Size and Region, 2018
Table 20: North American Stem Cell and Regenerative Medicines Market, by Country, Through 2024
Table 21: European Stem Cell and Regenerative Medicines Market, by Country, Through 2024
Table 22: Asia-Pacific Stem Cell and Regenerative Medicines Market, by Country, Through 2024
Table 23: Regenerative Medical Products Approved in Japan Since the New Regenerative Medicine Legislation
Table 24: Japan Tissue Engineering and Regeneration Technologies Patents, 2016-February 2019
Table 25: Europe Tissue Engineering and Regeneration Technologies Patents, 2016-February 2019
Table 26: U.S. Tissue Engineering and Regeneration Technologies Patents, 2016-February 2019
Table 27: Abbreviations Used in This Report
LIST OF FIGURES
Summary Figure: Global Stem Cell and Regenerative Medicines Market Share, by Region, 2018
Figure 1: Early Development of Embryo
Figure 2: Global Stem Cell and Regenerative Medicines Market Share, by Product, 2018
Figure 3: Global Stem Cell and Regenerative Therapeutic Products Market, 2018-2024
Figure 4: Global Stem Cell and Regenerative Therapeutic Products Market Share, by Type, 2018
Figure 5: Global Cell Therapy Market, 2018-2024
Figure 6: Global Tissue Engineering Market, 2018-2024
Figure 7: Global Prevalence of Diabetes, by Region, 2017
Figure 8: Global Gene Therapy Market, 2018-2024
Figure 9: Global Cell Banking Market, 2018-2024
Figure 10: Global Tools and Reagents Market, 2018-2024
Figure 11: Global Stem Cell and Regenerative Medicines Market Share, by Application, 2018
Figure 12: Global Stem Cell and Regenerative Medicines Market for Oncology, 2018-2024
Figure 13: T-cell Therapy Technique
Figure 14: Global Segmentation for Cancer Stem Cells Market
Figure 15: Global Stem Cell and Regenerative Medicines Market for Cardiovascular Disorders, 2018-2024
Figure 16: Global Stem Cell and Regenerative Medicines Market for Dermatology, 2018-2024
Figure 17: Global Stem Cell and Regenerative Medicines Market for Orthopedics, 2018-2024
Figure 18: Global Number of Surgeries, 2012-2020
Figure 19: Global Stem Cell and Regenerative Medicines Market for Central Nervous System Disorders, 2018-2024
Figure 20: Global Stem Cell and Regenerative Medicines Market for Diabetes, 2018-2024
Figure 21: Global Stem Cell and Regenerative Medicines Market for Other Applications, 2018-2024
Figure 22: Global Stem Cell and Regenerative Medicines Market Share, by Region, 2018
Figure 23: Regenerative Medicine Companies, by Size and Region, 2018
Figure 24: North American Stem Cell and Regenerative Medicines Market Share, by Country, 2018
Figure 25: U.S. Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 26: Potential U.S. Patient Populations for Cell-Based Therapies, 2016
Figure 27: NIH Stem Cell Research Spending, 2013-2018
Figure 28: Canadian Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 29: Mexican Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 30: European Stem Cell and Regenerative Medicines Market Share, by Country, 2018
Figure 31: German Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 32: Health Spending Throughout Germany, by Source, 2015 and 2040 (Est.)
Figure 33: U.K. Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 34: French Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 35: Italian Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 36: Spanish Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 37: Rest of Europe Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 38: Asia-Pacific Stem Cell and Regenerative Medicines Market Share, by Country, 2018
Figure 39: Japanese Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 40: Chinese Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 41: Indian Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 42: Rest of Asia-Pacific Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 43: South American Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 44: Middle East and African Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 45: Factors Driving M&A Deals Across the Life Science Sector
Summary Figure: Global Stem Cell and Regenerative Medicines Market Share, by Region, 2018
Figure 1: Early Development of Embryo
Figure 2: Global Stem Cell and Regenerative Medicines Market Share, by Product, 2018
Figure 3: Global Stem Cell and Regenerative Therapeutic Products Market, 2018-2024
Figure 4: Global Stem Cell and Regenerative Therapeutic Products Market Share, by Type, 2018
Figure 5: Global Cell Therapy Market, 2018-2024
Figure 6: Global Tissue Engineering Market, 2018-2024
Figure 7: Global Prevalence of Diabetes, by Region, 2017
Figure 8: Global Gene Therapy Market, 2018-2024
Figure 9: Global Cell Banking Market, 2018-2024
Figure 10: Global Tools and Reagents Market, 2018-2024
Figure 11: Global Stem Cell and Regenerative Medicines Market Share, by Application, 2018
Figure 12: Global Stem Cell and Regenerative Medicines Market for Oncology, 2018-2024
Figure 13: T-cell Therapy Technique
Figure 14: Global Segmentation for Cancer Stem Cells Market
Figure 15: Global Stem Cell and Regenerative Medicines Market for Cardiovascular Disorders, 2018-2024
Figure 16: Global Stem Cell and Regenerative Medicines Market for Dermatology, 2018-2024
Figure 17: Global Stem Cell and Regenerative Medicines Market for Orthopedics, 2018-2024
Figure 18: Global Number of Surgeries, 2012-2020
Figure 19: Global Stem Cell and Regenerative Medicines Market for Central Nervous System Disorders, 2018-2024
Figure 20: Global Stem Cell and Regenerative Medicines Market for Diabetes, 2018-2024
Figure 21: Global Stem Cell and Regenerative Medicines Market for Other Applications, 2018-2024
Figure 22: Global Stem Cell and Regenerative Medicines Market Share, by Region, 2018
Figure 23: Regenerative Medicine Companies, by Size and Region, 2018
Figure 24: North American Stem Cell and Regenerative Medicines Market Share, by Country, 2018
Figure 25: U.S. Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 26: Potential U.S. Patient Populations for Cell-Based Therapies, 2016
Figure 27: NIH Stem Cell Research Spending, 2013-2018
Figure 28: Canadian Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 29: Mexican Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 30: European Stem Cell and Regenerative Medicines Market Share, by Country, 2018
Figure 31: German Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 32: Health Spending Throughout Germany, by Source, 2015 and 2040 (Est.)
Figure 33: U.K. Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 34: French Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 35: Italian Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 36: Spanish Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 37: Rest of Europe Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 38: Asia-Pacific Stem Cell and Regenerative Medicines Market Share, by Country, 2018
Figure 39: Japanese Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 40: Chinese Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 41: Indian Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 42: Rest of Asia-Pacific Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 43: South American Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 44: Middle East and African Stem Cell and Regenerative Medicines Market, 2018-2024
Figure 45: Factors Driving M&A Deals Across the Life Science Sector
